Unknown PHASE4 INTERVENTIONAL 4-arm NCT01499407

Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction (COCTAIL II)

A Randomized Trial to Compare Four Different Intracoronary Modalities to Reduce Thrombus Burden and Improve Microcirculatory Function in Patients With ST-elevation Myocardial Infarction: Rationale and Design of the COCTAIL II Study

Sponsor: CLI Foundation

Conditions ST-elevation Myocardial Infarction

Interventions Abciximab ClearWay RX catheter

Updated 5 times since 2017 Last updated: Jan 2, 2012 Started: Dec 31, 2011 Primary completion: Dec 31, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on ST-elevation Myocardial Infarction, this trial is ongoing. The trial is conducted by CLI Foundation and has accumulated 5 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CLI Foundation

Data source: CLI Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy